Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Joined Kuros in 2018
John Griffin has over 20 years of experience providing leadership in General Management, Sales, Marketing, Innovation and Competitive Strategy in the Musculoskeletal and Biotechnology spaces. Having been an advisor to Kuros Biosurgery since 2017, Mr. Griffin helped to establish Kuros Biosciences Inc. in April 2018 and was appointed Head of Commercial Operations at that time. John Griffin became Chief Commercial Officer of Kuros Biosciences in 2023.
Mr. Griffin previously held roles of increasing responsibility in New Product Development, Marketing, Professional Education and Sales Leadership at DePuy International, DePuy Spine Inc. (Johnson and Johnson companies), ConforMIS and Benvenue Medical. He has a record of serial success with developing innovative technologies, Global Product launches and all aspects of commercial execution. John is well known as a trusted and respected commercial partner in the Spine Surgery community.
Mr. Griffin holds an MBA from Yale University having completed a highly specialized joint program in Healthcare Leadership within the Yale Schools of Medicine, Management, and Public Policy. He holds a BSc in Medical Sciences from the University of Leeds in the UK. Mr. Griffin has also been named on several patents for innovative technologies to improve musculoskeletal care.
Are you a good fit for these available positions?